Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
03:30:43 EDT Thu 18 Apr 2024
Enter Symbol
or Name
USA
CA



V:NRX - NurExone Biologic Inc. - http://www.nurexone.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
NRX - V  2.00.60·0.652.00.65+0.0814.073.543480.60  0.66  0.581.19  0.185Apr 17Apr 0215 min RT 2¢
TSX-V - V2.00.60·0.652.00.60+0.035.337.322210.60  0.66  0.581.19  0.185Apr 1715 min
NEO ATS - U 0.64+0.0712.35.0320.60  0.64  0.60Apr 1715 min
Omega - O 0.58+0.011.83.0230.58  0.58  0.58Apr 1715 min
CX2 - H 0.65+0.0814.027.016160.58  0.65  0.58Apr 1715 min
TriAct - M 0.571.316    15 min

Recent Trades - Last 10 of 48
Time ETExPriceChangeVolumeBuyerSellerMarkers
15:56:35H0.650.0850033 Canaccord1 AnonymousK
15:56:35U0.640.072,50033 Canaccord1 AnonymousK
15:30:15V0.600.033,00033 Canaccord1 AnonymousK
14:50:28M0.600.032001 Anonymous13 InstinetE
14:38:44M0.630.064501 Anonymous1 AnonymousE
14:01:48U0.600.032,500124 Questrade2 RBCK
14:01:39V0.600.033,0001 Anonymous2 RBCK
14:01:39V0.600.032,50079 CIBC2 RBCK
14:01:39H0.600.032,000124 Questrade2 RBCK
14:01:25V0.660.092,0002 RBC79 CIBCK

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2024-04-02 13:17C:NRX0.78News ReleaseNurexone spends $1.54-million (U.S.) on R&D in 2023
2024-04-02 08:53C:NRX0.78SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2024-04-02 08:18C:NRX0.78SEDAR MD & ASEDAR MD & A
2024-03-27 17:18C:NRX0.76News ReleaseNurexone receives $3.95-million from warrant exercise
2024-03-22 17:17C:NRX0.65News ReleaseNurexone signs deal with Vivox to test Exopten
2024-03-15 16:12C:NRX0.74News ReleaseNurexone shares to list on OTCQB Venture Market
2024-03-08 16:11C:NRX0.82News ReleaseNurexone finalizes lease for Israeli R&D facility
2024-02-20 16:27C:NRX1.09News ReleaseNurexone expands IP portfolio with ExoTherapy platform
2024-02-14 16:34C:NRX0.48News ReleaseNurexone to try to license ExoTherapy
2024-02-02 16:14C:NRX0.305News ReleaseNurexone starts European regulatory process for ExoPTEN
2024-01-17 13:20C:NRX0.265News ReleaseNurexone begins spinal cord research with Inteligex
2024-01-16 18:58C:NRX0.265Private PlacementNurexone Biologic 7,091,993-share private placement
2024-01-05 09:37C:NRX0.295News ReleaseNurexone closes $1.98-million private placement
2023-11-29 14:25C:NRX0.31News ReleaseNurexone Biologic develops 2 RNA sequences
2023-11-24 09:51C:NRX0.31News ReleaseNurexone spends $400,000 (U.S.) on R&D in Q3 2023
2023-11-24 08:08C:NRX0.31SEDAR Interim MD & ASEDAR Interim MD & A
2023-11-24 08:06C:NRX0.31SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-10-30 09:33C:NRX0.31News ReleaseNurexone receives orphan drug designation for ExoPTEN
2023-10-19 13:32C:NRX0.295News ReleaseNurexone adds Dagi to scientific advisory board
2023-10-11 12:00C:NRX0.26News ReleaseNurexone to receive $350,000 grant in Israel